| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/21/1996 | EP0697106A1 Electrochemiluminescent process |
| 02/21/1996 | EP0697021A1 Photo-activatable biotin derivatives and their use in suppressing interference in immuno assaying |
| 02/21/1996 | EP0696935A1 Large pore synthetic polymer membranes |
| 02/21/1996 | EP0696933A1 Composition and method for enrichment of white blood cells from whole human blood |
| 02/21/1996 | EP0593764B1 Dental testing composition |
| 02/21/1996 | EP0554398B1 System and method for monitoring the concentration of volatile material dissolved in a liquid |
| 02/21/1996 | EP0540573B1 Assay of free and complexed prostate-specific antigen (psa) |
| 02/21/1996 | EP0529000B1 NOx SENSOR ASSEMBLY |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/21/1996 | CN1117298A Disinfection of aqueous solutions |
| 02/20/1996 | US5493226 Method and apparatus for measuring properties of core samples including heating and pressurizing the core sample and measuring the dynamic and static capillary pressure of water in the core sample |
| 02/20/1996 | US5492841 Medical diagnosis |
| 02/20/1996 | US5492840 Surface plasmon resonance sensor unit and its use in biosensor systems |
| 02/20/1996 | US5492839 Immunogenic ryanodine derivative and related uses |
| 02/20/1996 | US5492835 Swab identification testing device and method |
| 02/20/1996 | US5492834 Pretreating a clinical fluid with a size exclusion gel to remove interfering low molecular weight species |
| 02/20/1996 | US5492833 Reticulocyte analyzing method and apparatus utilizing light scatter techniques |
| 02/20/1996 | US5492832 Controlling temperature to produce low levels of sulfur dioxide, oxidizing mainly carbon present |
| 02/20/1996 | US5492821 Diagnostics, food industry |
| 02/20/1996 | US5492814 Paramagnetic particles |
| 02/20/1996 | US5492813 Muteins of β-galactosidase fragments having increased activity |
| 02/20/1996 | US5492812 Diagnostic method for Alzheimer's disease by screening for tau-peptides in the blood of a patient |
| 02/20/1996 | US5492811 Bacterial diagnostic probe |
| 02/20/1996 | US5492807 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
| 02/20/1996 | US5492674 Disposable fiber optic apparatus for assaying fluid sample with radiation capable of exciting fluorescence |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/20/1996 | US5492117 System and method for assessing medical risk |
| 02/20/1996 | US5492023 Apparatus for automatically determining rate of plasticizer absorption of resin powder |
| 02/20/1996 | US5492005 System and method for determining deposit formation and mitigation by fuel additives |
| 02/20/1996 | US5492004 Measurement of hydrogen leakage through stator windings into generator coolant water and oxygenation of the coolant water |
| 02/20/1996 | US5491876 Needle-based apparatus for individualizing single fibers and other textile entities for testing puposes |
| 02/20/1996 | CA2068475C Biosensor and its manufacture |
| 02/20/1996 | CA1338069C Bovine herpesvirus type 1 polypeptides and vaccines |
| 02/15/1996 | WO1996004676A1 Mass spectrometer for macromolecules with cryogenic particle detectors |
| 02/15/1996 | WO1996004560A1 Improved activated protein c resistance test |
| 02/15/1996 | WO1996004559A1 Method for separating and/or screening and/or quantifying one or more infectious compounds and support for implementing said method |
| 02/15/1996 | WO1996004558A1 Measurement system using whole blood |
| 02/15/1996 | WO1996004557A2 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 02/15/1996 | WO1996004556A1 Lipoprotein cholesterol assays |
| 02/15/1996 | WO1996004555A1 Detergent-facilitated immunoassay of pharmacological agents |
| 02/15/1996 | WO1996004554A1 Urinary test strip for determining calcium loss |
| 02/15/1996 | WO1996004553A1 Automated work station for analyzing soil samples |
| 02/15/1996 | WO1996004552A1 Method for measuring total body tissue iron stores |
| 02/15/1996 | WO1996004551A1 Animal fat assessment |
| 02/15/1996 | WO1996004550A1 Electrochemical gas sensor with reduced cross-sensitivity |
| 02/15/1996 | WO1996004547A1 Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
| 02/15/1996 | WO1996004544A1 Method and apparatus for performing automated analysis |
| 02/15/1996 | WO1996004543A1 Pseudo telecentric optical design for flow cytometric blood cell analyzer |
| 02/15/1996 | WO1996004403A1 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 02/15/1996 | WO1996004401A1 Method and device for measuring the concentration of a substance in a solution |
| 02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/15/1996 | WO1996004372A1 Ikaros transgenic cells and animals |
| 02/15/1996 | WO1996004340A1 Conducting electroactive biomaterials |
| 02/15/1996 | WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 02/15/1996 | WO1996004311A1 Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease |
| 02/15/1996 | WO1996004309A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | WO1996004302A1 Novel tumor marker for lung cancer |
| 02/15/1996 | WO1996004300A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 02/15/1996 | WO1996004188A1 Control and/or monitoring of the condition of plant material |
| 02/15/1996 | WO1996004067A1 Membrane filter unit |
| 02/15/1996 | WO1996004019A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 02/15/1996 | WO1996004010A1 Vr-2332 viral nucleotide sequence and methods of use |
| 02/15/1996 | WO1996003993A2 Modulation of thymocyte and t cell functional activity |
| 02/15/1996 | WO1996003929A1 Method for prediction of premature delivery using estetrol (e4) as an indicator |
| 02/15/1996 | WO1996002645A3 Htk ligand |
| 02/15/1996 | WO1996000586A3 Methods for treating cell proliferative disorders by modulating signal transduction |
| 02/15/1996 | WO1996000083A3 Method of isolating an antigene preparation |
| 02/15/1996 | WO1995035490A3 Process, devices and use of said devices for measuring extinction of turbid suspensions |
| 02/15/1996 | WO1995032285A3 Transgenic arthritic mice |
| 02/15/1996 | WO1995031887A3 Exothermic fatigue measurement method of viscoelastic body and hydraulic servo system flexometer |
| 02/15/1996 | WO1995019169A3 Treatment of platelet derived growth factor related disorders such as cancer using inhibitors of platelet derived growth factor receptor |
| 02/15/1996 | DE4427921A1 Chemische Sensoren, insbesondere Biosensoren, auf Siliciumbasis Chemical sensors, in particular biosensors, based on silicon |
| 02/15/1996 | DE4427438A1 Plant photosynthesis measurement by application of step light pulses |
| 02/15/1996 | DE4427316A1 Non contact tablet tester guards against defects which can reduce dose |
| 02/15/1996 | DE4427314A1 Gas analysis device for analysing gaseous content of container |
| 02/15/1996 | DE19511948A1 Sepg. device for small components, e.g. tablets and capsules |
| 02/15/1996 | DE19511854A1 Device for testing small components, e.g. tablets, quickly |
| 02/15/1996 | CA2196776A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 02/15/1996 | CA2196679A1 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 02/15/1996 | CA2196559A1 Method for measuring total body tissue iron stores |
| 02/15/1996 | CA2196546A1 Urinary test strip for determining calcium loss |
| 02/15/1996 | CA2196204A1 Detergent-facilitated immunoassay of pharmacological agents |
| 02/15/1996 | CA2196195A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 02/15/1996 | CA2196190A1 Ikaros transgenic cells and animals |
| 02/15/1996 | CA2195672A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/15/1996 | CA2171545A1 Automated work station for analyzing soil samples |
| 02/14/1996 | EP0696736A1 Detection of high risk factor to develop cataract and a reagent kit for the detection |
| 02/14/1996 | EP0696735A1 Controlled sensitivity immunochromatographic assay |
| 02/14/1996 | EP0696731A2 Cytoanalyzer |
| 02/14/1996 | EP0696730A1 Agents and a method of chromosome preparation using protein phosphatase inhibitors induced premature chromosome condensation (PCC) technique |
| 02/14/1996 | EP0696643A1 Apparatus for inhibiting glycolysis in blood samples |
| 02/14/1996 | EP0696642A1 Process for the detection of disorders of the protein C/protein S system |
| 02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
| 02/14/1996 | EP0696597A2 Monoclonal antibodies for selective immunological determination of high molecular weight intact laminin forms in body fluids |
| 02/14/1996 | EP0696596A1 Detection, assay and isolation of compounds having the taxane ring skeleton |
| 02/14/1996 | EP0696434A1 Collection assembly |
| 02/14/1996 | EP0696352A1 Method of analyzing tumor cell dna content through tumor cell enrichment |
| 02/14/1996 | EP0696326A1 Methods of treating and detecting cancer using viruses |
| 02/14/1996 | EP0696325A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |